Sysmex Corp - Company Profile
Powered by 
All the sales intelligence you need on Sysmex Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Sysmex Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Sysmex Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
Business Description
Sysmex Corp (Sysmex) develops, manufactures and markets diagnostic instruments, reagents and related software products for analyzing samples of blood, urine and cells. It also offers devices and technologies for gene, cell and protein analysis. The company’s products are used in testing during health checkups, treatment and disease management. The company offers its products to medical institutions, universities, research institutions, national and other public hospitals.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Sysmex is expanding its technology in the diagnostics business, particularly in hematology. The company is also developing new technologies for the social implementation of high-clinical-value diagnostic and liquid biopsy technologies. This is aimed at refining personalized medicine and testing. Sysmex is also working on expanding into new markets and enhancing the value of testing and diagnosis by expanding the scope of testing. The company is also developing technologies for personalized prevention and prognosis monitoring. Sysmex is leveraging its strengths in therapeutic areas such as medical robotics and regenerative medicine. In FY2025, the company spent JPY31,402 million on its R&D, which as a percentage of revenue, stood at 6.8%.
Business Segments
Overview
Focuses on in vitro diagnostics (IVD), specializes in the collection and analysis of biological samples like blood and urine. This diagnostic approach supports disease prevention, diagnosis, treatment determination, and post-treatment monitoring, making accurate results vital for effective patient care. Various areas of diagnostics, include hematology, where it offers a comprehensive range of products, and hemostasis testing, collaborating with Siemens Healthineers and HYPHEN BioMed. The segment also excels in urinalysis, having developed the first automated urine particle analyzer, and immunochemistry, which provides rapid and sensitive testing for infectious diseases and cancer markers. Additionally, the segment is pioneering cancer gene testing with its OSNA method, enabling efficient detection of lymph node metastasis and contributing to tailored cancer treatment strategies.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Focuses on the areas of minimally invasive laparoscopic surgery, which aims to lessen patient recovery time and discomfort. Insurance coverage for robotic-assisted surgeries has expanded to include urology, gastroenterology, and gynecology, contributing to an increase in such procedures. Additionally, there is potential for these robots to facilitate remote surgeries, allowing doctors and patients to be in different locations during operations.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer